Effects of Trade Related Intellectual Property Rights on the research and development expenditure of Indian pharmaceutical industry

@article{Banerjee2014EffectsOT,
  title={Effects of Trade Related Intellectual Property Rights on the research and development expenditure of Indian pharmaceutical industry},
  author={Tannista Banerjee and Arnab Nayak},
  journal={Journal of Pharmaceutical Health Services Research},
  year={2014},
  volume={5}
}
This article investigates the factors that affect the research and development (R&D) expenditure of Indian pharmaceutical industry before and after the introduction of Trade Related Intellectual Property Rights, January 1995. 

References

SHOWING 1-10 OF 16 REFERENCES
The determinants of pharmaceutical research and development expenditures
Abstract. Since the late 1970s, pharmaceutical R&D has grown at a rapid rate relative to sales and other variables. In this paper, we examine the determinants of pharmaceutical R&D using a pooled
Pharmaceutical Patents, Prices and Welfare Losses: Policy Options for India Under the WTO TRIPS Agreement
  • J. Watal
  • Economics, Political Science
  • 2000
C ONCERNS on the effect of product patents on the prices of medicines have been acute in many developing countries which, up to the entry into force of the World Trade Organisation (WTO) Agreement on
Scale, Scope and Spillovers: The Determinants of Research Productivity in Ethical Drug Discovery
We examine the relationship between firm size and research productivity in the pharmaceutical industry. Using detailed internal firm data, we find that larger research efforts are more productive,
Scale, scope, and spillovers: the determinants of research productivity in drug discovery.
TLDR
It is found that larger research efforts are more productive, not only because they enjoy economies of scale, but also because they realize economies of scope by sustaining diverse portfolios of research projects that capture internal and external knowledge spillovers.
R&D and productivity in the Indian pharmaceutical firms
Recent researches for developing countries suggest knowledge generating activates is no silver bullet for productivity growth. In this context, this paper examines the impact of R&D activities on
Post‐TRIPS Options for Access to Patented Medicines in Developing Nations
This article explores the tension between granting patent protection under the TRIPS Agreements and the availability of medicines at affordable prices to developing countries. A crucial consideration
Linkages and technology spillovers in the presence of foreign firms: Evidence from the Indian pharmaceutical industry
Purpose - This paper aims to examine production linkage and technology spillovers due to the presence of foreign firms in the Indian pharmaceutical industry. Design/methodology/approach - This study
The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan
During the past 20 years, the world pharmaceutical industry has experienced a dramatic increase in R&D intensity. We apply and extend a model developed by Grabowski and Vernon (2000, Journal of
The productivity crisis in pharmaceutical R&D
TLDR
This study examines the decline of R&D productivity in pharmaceuticals in the past two decades and shows that this decline is associated with an increasing concentration ofR&D investments in areas in which the risk of failure is high, which correspond to unmet therapeutic needs and unexploited biological mechanisms.
...
...